Some problems about transplantation immunity in bone tissue engineering

RC Lei,XC Jian

DOI: https://doi.org/10.3321/j.issn:1673-8225.2007.02.041

2007-01-01

Abstract:Objective: To investigate the progression of transplantation immunity in bone tissue engineering. Data sources: An online search of American NCBI Pubmed database was undertaken to identify English articles about transplantation immunity and bone tissue engineering between January 1998 and January 2006 by using keywords of "bone tissue engineering, scaffold, antigen, immunity"and relevant articles published in Chinese with the keywords of "bone tissue-engineering, transplantation immunity, natural bio-scaffold" from January 2002 to January 2006 were applied. Study selection: The original experimental articles and the reviews that reported the transplantation immunity and bone tissue engineering were selected. Inclusive criteria: 1 Original and reliable experimental articles, 2 well analyzed reviews with clear opinions, 3 articles with close relationship with the topic in this paper. Exclusive criteria: Articles with obvious errors in the experimental design or result and reviews with obscure opinions. Quality evaluation mainly inspected the validity of data and whether the experimental duration was accurate or not. Data extraction: Totally 65 articles about transplantation immunity and bone tissue engineering were collected, and 34 articles were accorded with the inclusive criteria. Data synthesis: A total of 34 articles analyzed the host immune response to xenogeneic extracellular matrix scaffolds, mesenchymal stem cells, xenogeneic serum medium, and investigated the mechanism of transplantation immunity. At last, those articles discussed how to preserve the structure of the natural extracellular matrix, avoid the transplantation immunity and analyzed the factor related to cell conglutination. 1 The antigen of the scaffold derived from heterogeneous natural bone was vascular endothelial cell and osteocyte. Autogenous, homogenous, allograft or allogeneic cell could be used in bone tissue engineering, whereas heterogenous cell could not be used in bone tissue engineering. 2 Obvious cell response was shown around natural extracellular matrix, and those major cells were monocyte, no definite mark, and no plasma cell was observed. Th1 and Th2 lymphocytes in cell mediated immune responses to (cellular) xenografts and the major immunoreaction that was shown after implantation was transient inflammation. 3 Microencapsulation could provide preferable immunoinsulation and biocompatibility. Immuno-suppressant could advance osteogenesis, and modification could change the surface structural feature, aperture, porosity of the scaffold and advance attachment, proliferation and growth of cell. Conclusion: The natural extracellular matrix, mesenchymal stem cells, xenogeneic serum medium in bone tissue engineering can bring heteroantigens. The tissue cytokine such as Th1 and Th2 lymphocytes mediated immune responses to extracellular matrix, and the immunoreaction was transient. Immuno-isolation, immunosuppressant, modification of the natural extracellular matrix can suppress the immunoreaction.